Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1199527011 | Dexrazoxane hydrochloride 250mg/vial powder (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 1212660013 | Dexrazoxane hydrochloride 250mg/vial powder | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dexrazoxane hydrochloride 250mg/vial powder | Is a | Antidote agent | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Is a | Cytoprotective agent | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Has active ingredient | Cytoprotective agent | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Is a | Dexrazoxane hydrochloride | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Has active ingredient | Dexrazoxane | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Has active ingredient | Chelating agent | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Has active ingredient | Razoxane | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Dexrazoxane hydrochloride 250mg/vial powder | Is a | Dexrazoxane-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR